Neuronetics is trading 5.28% up at $2.99 in pre-market on September 1, 2026, with no confirmed company-specific catalyst identified.

  • Recent second-quarter results and insider buying predate the move and are not confirmed drivers.
  • Broader futures are modestly lower, so market sentiment does not clearly explain the gain.
  • Limited early-session liquidity or delayed company interest may be factors; volume and later news require confirmation.